The Joint Basic and Translational Scientific Meeting, cohosted by the American Society for Transplantation and Cellular ...

Preclinical data demonstrate deep and durable tumor regressions with lead product candidate ERNA-101 in combination with PD-1 ...

Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company"), today provided an update on its ongoing pharmacokinetic (PK) clinical program supporting the treatment of surgically eligible ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

Tiger Woods told investigators he was looking at his cell phone before a rollover crash. Woods was arrested on a DUI charge ...

Indian firms hoping to ride the global biologics boom are finding the path far tougher than expected, as China tightens its ...

Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive ...

HCW Biologics Inc. (the 'Company” or 'HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing ...

Toyota intends to become an equal shareholder in cellcentric alongside Daimler Truck and the Volvo Group.

Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck can ...

PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative lo ...